Role of natural fatty acids in prophylaxis and treatment of cardiovascular diseases

1. Karłowicz-Bodalska K, Bodalski T. Nienasycone kwasy tłuszczowe, ich właściwości biologiczne i znaczenie w lecznictwie. Post Fitoter 2007; 1:46-56. Search in Google Scholar

2. Materac E, Marczyński Z, Bodek KH, Rola kwasów tłuszczowych omega-3 i omega-6 w organizmie człowieka. Bromat Chem Toksykol 2013; XLVI, 2:225-233. Search in Google Scholar

3. Dutkowska A, Rachoń D. Rola kwasów tłuszczowych n-3 oraz n-6 w prewencji chorób układu sercowo-naczyniowego. Choroby Serca i Naczyń 2015; 12(3):154-159. Search in Google Scholar

4. Hooper L, Al-Khudairy L, Abdelhamid AS, Rees K, Brainard JS, Brown TJ, Ajabnoor SM et al. Omega-6 fats for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev 2018; 11:CD011094. doi: https://dx.doi.org/10.1002/14651858.CD011094.pub410.1002/14651858.CD011094.pub4651679930488422 Search in Google Scholar

5. Łoźna K, Kita A, Styczyńska M, Biernat J. Skład kwasów tłuszczowych olejów zalecanych w profilaktyce chorób cywilizacyjnych, Probl Hig Epidemiol 2012; 93(4):871-875. Search in Google Scholar

6. Ouellette RJ, Rawn JD. 5-Alkenes: structures and properties. In: Ouellette RJ, Rawn JD. Organic chemistry. 2^nd edition. Cambridge, Massachusetts. Academic Press. 2018; 135-165. doi: https://dx.doi.org/10.1016/B978-0-12-812838-1.50005-010.1016/B978-0-12-812838-1.50005-0 Search in Google Scholar

7. Saini RK, Assefa AD, Keum YS. Spices in the Apiaceae family represent the healthiest fatty acid profile: a systematic comparison of 34 widely used spices and herbs. Foods 2021; 10(4):854. doi: https://dx.doi.org/10.3390/foods1004085410.3390/foods10040854807103633920058 Search in Google Scholar

8. L Choe U, Li Y, Zhang Y. Oils from fruit, spice, and herb seeds. Bailey’s industrial oil and fat products 2020; 1-35. doi: https://dx.doi.org/10.1002/047167849X.bio060.pub210.1002/047167849X.bio060.pub2 Search in Google Scholar

9. Kumar Saini R, Young-Soo Keum. Omega-3 and omega-6 polyunsaturated fatty acids: dietary sources, metabolism, and significance – a review. Life Sci 2018; 203:255-267. doi: https://dx,doi.org/10.1016/j.lfs.2018.04.04910.1016/j.lfs.2018.04.04929715470 Search in Google Scholar

10. Kitessa SM, Nichols PD, Abetwardena M. Purple viper’s bugloss (Echium plantagineum) seed oil in human health. Nuts & seeds in health and disease prevention. 2011; 112:951-958. doi: https://dx.doi.org/10.1016/B978-0-12-375688-6.10112-410.1016/B978-0-12-375688-6.10112-4 Search in Google Scholar

11. Saini RK, Prasad P, Sreedhar RV, Akhilender Naidu K, Shang X et al. Omega-3 polyunsaturated fatty acids (PUFAs): emerging plant and microbial sources, oxidative stability, bioavailability, and health benefits – a review. Antioxidants 2021; 10(10):1627. doi: https://dx.doi.org/10.3390/antiox1010162710.3390/antiox10101627853314734679761 Search in Google Scholar

12. Wołoszyn J, Haraf G, Okruszek A, Wereńska M, Goluch Z, et al. Fatty acid profiles and health lipid indices in the breast muscles of local Polish goose varieties. Poult Sci 2020; 99(2):1216-1224. doi: https://dx.doi.org/10.1016/j.psj.2019.10.02610.1016/j.psj.2019.10.026758767932036970 Search in Google Scholar

13. Jebari-Benslaiman S, Galicia-García U, Larrea-Sebal A, Olaetxea JR et al. Pathophysiology of atherosclerosis. Int J Mol Sci 2022; 23(6):3346. doi: https://dx.doi.org/10.3390/ijms2306334610.3390/ijms23063346895470535328769 Search in Google Scholar

14. Balk EM, Lichtenstein AH. Omega-3 fatty acids and cardiovascular disease: summary of the 2016 Agency of Healthcare Research and Quality Evidence Review. Nutrients 2017; 9(8):865.10.3390/nu9080865557965828800093 Search in Google Scholar

15. Khan SU, Lone AN, Khan MS, et al. Effect of omega-3 fatty acids on cardiovascular outcomes: a systematic review and meta-analysis. E Clinical Medicine 2021; 38:100997. doi: https://dx.doi:10.1016/j.eclinm.2021.10099710.1016/j.eclinm.2021.100997841325934505026 Search in Google Scholar

16. Rimm EB, Appel LJ, Chiuve SE, Djoussé L, Engler MB, Kris-Etherton PM et al. Seafood long-chain n-3 polyunsaturated fatty acids and cardiovascular disease: A Science Advisory From the American Heart Association. Circulation 2018; 138:e35–e47. doi: https://dx.doi.org/10.1161/CIR.000000000000057410.1161/CIR.0000000000000574690377829773586 Search in Google Scholar

17. Miller PE, Van Elswyk M, Alexander DD. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials. Am J Hypertens 2014; 27(7):885-896. doi: https://dx.doi.org//10.1093/ajh/hpu02410.1093/ajh/hpu024405479724610882 Search in Google Scholar

18. Calder PC. Eicosanoids. Essays Biochem 2020; 64(3):423-441. doi: https://dx.doi.org/10.1042/EBC2019008310.1042/EBC2019008332808658 Search in Google Scholar

19. De Caterina R. N–3 fatty acids in cardiovascular disease. N Engl J Med 2011; 364:2439-2450. doi: https://dx.doi.org/10.1056/NEJMc110837510.1056/NEJMc110837521992140 Search in Google Scholar

20. Cao L. Is there evidence to support the use of omega-3 fatty acids in preventing cardiovascular events? The NYU Langone Health Online Journal of Medicine. Clinicla Correlations 2019. Search in Google Scholar

21. Siscovick DS, Barringer TA, Fretts AM, Wu JH, Lichtenstein AH, Costello RB et al. Omega-3 polyunsaturated fatty acid (fish oil) supplementation and the prevention of clinical cardiovascular disease, Circulation 2017; 135:e867–e884. doi: https://dx.doi.org/10.1161/CIR.000000000000048210.1161/CIR.0000000000000482690377928289069 Search in Google Scholar

22. Hopper L, Ness A, Higgins JP, Moore T, Ebrahim S. Dietary supplementation with n-3 polyunsatu-rated fatty acids and vitamin E after myocardial infarction: results of the GISSI-prevenzione trial. Lancet 1999; 354(9177):447-55. doi: https://dx.doi.org/10.1056/NEJMoa100360310.1056/NEJMoa100360320929341 Search in Google Scholar

23. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y et al. Japan EPA lipid intervention study (JELIS) investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007; 369(9567):1090-8. doi: https://dx.doi.org/10.1016/S0140-6736(07)60527-310.1016/S0140-6736(07)60527-317398308 Search in Google Scholar

24. Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, et al. Gissi-HF Investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSIHF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008; 372(9645):1223-30. doi: https://dx.doi.org/10.1016/S0140-6736(08)61239-810.1016/S0140-6736(08)61239-818757090 Search in Google Scholar

25. Kromhout D, Giltay EJ, Geleijnse JM. For Alpha Omega Trial Group. N-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 2010; 363(21):2015-26. doi: https://dx.doi.org/10.1056/NEJMoa100360310.1056/NEJMoa1003603 Search in Google Scholar

26. Rauch B, Schiele R, Schneider S, Diller F, Victor N, Gohlke H et al. For OMEGA Study Group. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation 2010; 122(21):2152-9. doi: https://dx.doi.org/10.1161/CIRCULATIONAHA.110.94856210.1161/CIRCULATIONAHA.110.94856221060071 Search in Google Scholar

27. Galan P, Kesse-Guyot E, Czernichow S, Briancon S, Blacher J, Hercberg S et al. Effects of B vitamins and omega-3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial, BMJ 2010; 341:c6273. doi: https://dx.doi.org/10.1136/bmj.c627310.1136/bmj.c6273299304521115589 Search in Google Scholar

28. Bosch J, Gerstein HC, Dagenais GR, Díaz R, Dyal L, Jung H et al. The ORIGIN trial investigators, n–3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 2012; 367:309-318. doi: http://dx.doi.org/10.1056/NEJMoa120385910.1056/NEJMoa120385922686415 Search in Google Scholar

29. Roncaglioni MC, Tombesi M, Avanzini F, Barlera S, Caimi V, Longoni P et al. For risk and prevention study collaborative group. N-3 fatty acids in patients with multiple cardiovascular risk factors. N Engl J Med 2013; 368(19):1800-8. doi: http://dx.doi.org/10.1056/NEJMoa120540910.1056/NEJMoa120540923656645 Search in Google Scholar

30. Bowman L, Mafham M, Wallendszus K, Stevens W, Buck G, Barton J et al. For ASCEND study collaborative group. Effects of n-3 fatty acid supplements in diabetes mellitus. N Engl J Med 2018; 379(16):1540-1550. doi: http://dx.doi.org/10.1056/NEJMoa180498910.1056/NEJMoa180498930146932 Search in Google Scholar

31. Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S et al. For the VITAL research group. Marine n−3 fatty acids and prevention of cardiovascular disease and cancer. N Engl J Med 2019; 380:23-32. doi: http://dx.doi.org/10.1056/NEJMoa181140310.1056/NEJMoa1811403639205330415637 Search in Google Scholar

32. Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB et al. For the REDUCE-IT investigators. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med 2019; 380:11-22. doi: http://dx.doi.org/10.1056/NEJMoa181279210.1056/NEJMoa181279230415628 Search in Google Scholar

33. Abdelhamid AS, Martin N, Bridges C, Brainard JS, Wang X, Brown TJ et al. Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev 2018; 11:CD012345. doi: https://dx.doi.org/10.1002/14651858.CD012345.pub310.1002/14651858.CD012345.pub3651701230484282 Search in Google Scholar

34. Elagizi A, Lavie CJ, O’Keefe E, Marshall K, O’Keefe JH, Milani RV. An update on omega-3 polyunsaturated fatty acids and cardiovascular health. Nutrients 2021; 13(1):204. doi: http://dx.doi.org/10.3390/nu1301020410.3390/nu13010204782728633445534 Search in Google Scholar

35. Nicholls SJ, Lincoff AM, Garcia M, Bash D, Ballantyne CM, Barter PJ et al. Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: The STRENGTH Randomized Clinical Trial. JAMA 2020; 324(22):2268-2280. doi: http://dx.doi.org/10.1001/jama.2020.2225810.1001/jama.2020.22258766757733190147 Search in Google Scholar

36. Lichtenstein AH, Appel LJ, Vadiveloo M, Hu FB, Kris-Etherton PM, Rebholz CM et al. 2021 Dietary guidance to improve cardiovascular health: A Scientific Statement From the American Heart Association. Circulation 2021; 144:e472–e487. doi: http://dx.doi.org/10.1161/CIR.000000000000103110.1161/CIR.000000000000103134724806 Search in Google Scholar

37. Curfman G, Shehada E. Icosapent ethyl: scientific and legal controversies. Open Heart 2021; 8(1):e001616. doi: https://dx.doi.org/10.1136/openhrt-2021-00161610.1136/openhrt-2021-001616807086033888593 Search in Google Scholar

38. Visseren FJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Back M et al. ESC Guidelines on cardiovascular disease prevention in clinical practice, Eur 2021; 42:3227-3337. doi: http://dx.doi.org/10.1093/eurheartj/ehab48410.1093/eurheartj/ehab48434458905 Search in Google Scholar

• Chemical profiles and biological activities of acetone extracts of Curcuma xanthella
• Geranyl flavanone from Feronia limonia (L.) Swingle
• Evaluation of detoxification of aflatoxin-b1 by using Ag nanoparticles of oil extracts user prepared by using some medical herbs
• Synthetic seeds technology of Salvia officinalis as a method for short-term storage and in vitro propagation of valuable genotypes
• Morphological and biochemical responses of selected Ocimum species under drought